+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Polymerase Chain Reaction (PCR) Market (2018 - 2024)

  • ID: 4721657
  • Report
  • Region: Europe
  • 97 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • BioMérieux
  • Fluidigm Corporation
  • Hoffmann-La Roche Ltd
  • LGC Limited
  • Qiagen NV
  • MORE
The Europe Polymerase Chain Reaction Technologies Market is expected to witness market growth of 6.5% CAGR during the forecast period (2018 - 2024). Polymerase chain reaction technology devices are medical devices that are primarily used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are majorly used in different life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics. Additionally, the technology is also used in identifying criminals and child identity in various forensics departments. Growing geriatric population, growing prevalence of infectious diseases, rapidly growing diagnostic centers and hospitals, technological advancements, and growing awareness and acceptance of personalized medicine are the factors that drive the polymerase chain reaction technologies market. Nevertheless, growing non-validated home-brew tests and reimbursement issues are the factors that limit the growth of the market. Also, accuracy and timely results for RT-PCR is expected to further add to the challenges to the polymerase chain reaction technologies growth. Less tedious processes open avenues for the PCR market.

Based on Technology, the market is segmented into Real Time PCR, Digital PCR and Traditional PCR. Based on Application, the market is segmented into Forensics, Research and Clinical. Based on Product, the market is segmented into Instruments, Reagents & consumables, Software and Services. Based on End user, the market is segmented into Biotech & Pharma Company, Diagnostics Centers & Hospitals and Academic & Research Institutions. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • BioMérieux
  • Fluidigm Corporation
  • Hoffmann-La Roche Ltd
  • LGC Limited
  • Qiagen NV
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Polymerase Chain Reaction (PCR) Market, by Technology
1.4.2 Europe Polymerase Chain Reaction (PCR) Market, by Application
1.4.3 Europe Polymerase Chain Reaction (PCR) Market, by Product
1.4.4 Europe Polymerase Chain Reaction (PCR) Market, by End User
1.4.5 Europe Polymerase Chain Reaction (PCR) Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Polymerase Chain Reaction Technologies Market by Technology
3.1.1 Europe Real-Time PCR Market by Country
3.1.2 Europe Digital PCR Market by Country
3.1.3 Europe Traditional PCR Market by Country

Chapter 4. Europe Polymerase Chain Reaction Technologies Market by Application
4.1.1 Europe Polymerase Chain Reaction Technologies in Forensics Market by Country
4.1.2 Europe Polymerase Chain Reaction Technologies in Research Market by Country
4.1.3 Europe Polymerase Chain Reaction Technologies in Clinical Market by Country

Chapter 5. Europe Polymerase Chain Reaction Technologies Market by Product
5.1.1 Europe Polymerase Chain Reaction Technologies Instruments Market by Country
5.1.2 Europe Polymerase Chain Reaction Technologies Reagents & Consumables Market by Country
5.1.3 Europe Polymerase Chain Reaction Technologies Software Market by Country
5.1.4 Europe Polymerase Chain Reaction Technologies Services Market by Country

Chapter 6. Europe Polymerase Chain Reaction Technologies Market by End User
6.1.1 Europe Polymerase Chain Reaction Technologies in Biotech & Pharma Companies Market by Country
6.1.2 Europe Polymerase Chain Reaction Technologies in Diagnostic Centers & Hospitals Market by Country
6.1.3 Europe Polymerase Chain Reaction Technologies in Academic & Research Institutions Market by Country

Chapter 7. Europe Polymerase Chain Reaction Technologies Market by Country
7.1 Germany Polymerase Chain Reaction Technologies Market
7.1.1 Germany Polymerase Chain Reaction Technologies Market by Technology
7.1.2 Germany Polymerase Chain Reaction Technologies Market by Application
7.1.3 Germany Polymerase Chain Reaction Technologies Market by Product
7.1.4 Germany Polymerase Chain Reaction Technologies Market by End User
7.2 UK Polymerase Chain Reaction Technologies Market
7.2.1 UK Polymerase Chain Reaction Technologies Market by Technology
7.2.2 UK Polymerase Chain Reaction Technologies Market by Application
7.2.3 UK Polymerase Chain Reaction Technologies Market by Product
7.2.4 UK Polymerase Chain Reaction Technologies Market by End User
7.3 France Polymerase Chain Reaction Technologies Market
7.3.1 France Polymerase Chain Reaction Technologies Market by Technology
7.3.2 France Polymerase Chain Reaction Technologies Market by Application
7.3.3 France Polymerase Chain Reaction Technologies Market by Product
7.3.4 France Polymerase Chain Reaction Technologies Market by End User
7.4 Russia Polymerase Chain Reaction Technologies Market
7.4.1 Russia Polymerase Chain Reaction Technologies Market by Technology
7.4.2 Russia Polymerase Chain Reaction Technologies Market by Application
7.4.3 Russia Polymerase Chain Reaction Technologies Market by Product
7.4.4 Russia Polymerase Chain Reaction Technologies Market by End User
7.5 Spain Polymerase Chain Reaction Technologies Market
7.5.1 Spain Polymerase Chain Reaction Technologies Market by Technology
7.5.2 Spain Polymerase Chain Reaction Technologies Market by Application
7.5.3 Spain Polymerase Chain Reaction Technologies Market by Product
7.5.4 Spain Polymerase Chain Reaction Technologies Market by End User
7.6 Italy Polymerase Chain Reaction Technologies Market
7.6.1 Italy Polymerase Chain Reaction Technologies Market by Technology
7.6.2 Italy Polymerase Chain Reaction Technologies Market by Application
7.6.3 Italy Polymerase Chain Reaction Technologies Market by Product
7.6.4 Italy Polymerase Chain Reaction Technologies Market by End User
7.7 Rest of Europe Polymerase Chain Reaction Technologies Market
7.7.1 Rest of Europe Polymerase Chain Reaction Technologies Market by Technology
7.7.2 Rest of Europe Polymerase Chain Reaction Technologies Market by Application
7.7.3 Rest of Europe Polymerase Chain Reaction Technologies Market by Product
7.7.4 Rest of Europe Polymerase Chain Reaction Technologies Market by End User

Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Revenue & Segment analysis
8.1.4 Research and Development
8.2 Bio-Rad Laboratories, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 bioMérieux SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 Takara Bio Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Agilent Technologies
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Fluidigm Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.8 LGC Limited
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expense
8.9 Qiagen NV
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expense
8.1 SYGNIS Pharma AG
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agilent Technologies
  • BioMérieux
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • LGC Limited
  • Qiagen NV
  • SYGNIS Pharma AG
  • Takara Bio, Inc.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll